The divestiture simplifies IFF's portfolio to higher-growth Taste, Scent, and Health & Biosciences segments. The ~$3.8B cash inflow enables significant deleveraging and potential buybacks. Monitor regulatory timeline and Q2 2027 close; near-term EPS dilution is a headwind but the strategic refocusing and balance sheet improvement are positive catalysts. The reiterated 2026 guidance provides a floor for expectations.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 1 $74.26entry
- T+1 · 6mo ago −1.37%α −1.52% · $73.24
- T+5 · 5mo ago −1.68%α +1.07% · $73.01
- T+20 · 5mo ago +6.68%α +7.98% · $79.22
- T+60 · 3mo ago +17.37%α +16.14% · $87.16
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
IFF entered into a definitive agreement to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion (enterprise value), representing a ~10x EBITDA multiple. IFF expects net cash proceeds of ~$3.8 billion at closing and will retain a ~9.9% minority equity interest valued at ~$200 million. The transaction is expected to close by end of Q2 2027 and is dilutive to adjusted EPS in the first 12 months post-close.
Key Financial Metrics
Key Facts
- IFF agreed to sell its Food Ingredients business to CVC Capital Partners for ~$4.3 billion enterprise value (~10x EBITDA).
- IFF expects net cash proceeds of ~$3.8 billion at closing, plus a ~9.9% minority equity interest valued at ~$200 million.
- The Food Ingredients business generated ~$3.1 billion in sales and ~$430 million in EBITDA in 2025.
- Proceeds will be prioritized for debt reduction, targeted share repurchases, and reinvestment in core businesses.
- Transaction expected to close by end of Q2 2027, subject to regulatory approvals and customary conditions.
- IFF reiterated full-year 2026 guidance: sales $10.5B-$10.8B, adjusted operating EBITDA $2.05B-$2.15B.
- Transaction is expected to be dilutive to adjusted EPS in the first 12 months following closing.
- IFF has divested 13 non-core businesses including this one, generating nearly $10 billion in gross proceeds.
Financial Impact
~$4.3 billion enterprise value; ~$3.8 billion net cash proceeds; ~$200 million retained equity stake; ~10x EBITDA multiple
Risk Factors
- Transaction expected to be dilutive to adjusted EPS in first 12 months post-close.
- Closing not expected until end of Q2 2027, regulatory and execution risks over ~12-month period.
- Stranded overhead costs from the carve-out could pressure margins if not fully addressed.
- Retained minority stake (~10%) limits upside participation and introduces illiquidity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-249963 |
| Document: d118591dex991.htm | 0001193125-26-249963 |
| Document: 0001193125-26-249963-index-headers.html | 0001193125-26-249963 |
| Document: 0001193125-26-249963-index.html | 0001193125-26-249963 |
| Document: 0001193125-26-249963.txt | 0001193125-26-249963 |
Track record
13 reports on IFF
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $81.16 Now $79.99 −1.44% settles Feb 11
- Nov 3, 202613d ago 8-K Neutral 3/10 Entry $87.67 Now $79.99 −8.76% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $87.67 Now $79.99 −8.76% settles Feb 2
- Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $93.02 Now $79.99 −14.01% settles Jan 28
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $90.66 Now $79.99 −11.77% settles Jan 26
- Sep 11, 20269w ago ANALYST-UPGRADE Neutral 2/10 Entry $83.61 Now $79.99 −4.33% settles Dec 7
- Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $85.00 to $87.67 Now $79.99 −5.89% ▲ +3.14% +3.63% vs SPY
- Jul 20, 202617w ago Press Release Neutral 3/10 Entry $76.26 to $88.20 Now $79.99 +4.89% ▲ +15.66% +11.68% vs SPY
- Jun 23, 202620w ago 8-K Neutral 4/10 Entry $75.83 to $84.91 Now $79.99 +5.49% ▲ +11.97% +9.14% vs SPY
- Jun 9, 202622w ago ANALYST-UPGRADE Bullish 3/10 Entry $75.78 to $86.94 Now $79.99 +5.56% ▲ +14.73% +10.91% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers